HUMA
Humacyte, Inc. · Healthcare
Ayabudge LLC sold $1.6M of Humacyte, Inc.
10% owner
Sold$1,558,750
$3.12Price
500,000Shares
−5%Stake
What HUMA did after the filing
- The stock from Fri, Jun 16 close, $3.22
- −0.3%
- S&P 500, same days
- +3.9%
Measured over 30 trading days, to the Aug 1 close.
Traded Thu, Jun 15. Filed Fri, Jun 16, 12:04 PM ET, during the session. Returns use the Jun 16 close and the Aug 1 close. Not investment advice.